Association between serum levels Of Hs-CRP and LDL-C with degree of coronary artery stenosis in patients with stable angina pectoris

Iranian Red Crescent Medical Journal

Volumn 12, Issue 4, 2010, Pages 396-405

  Kojuri, J ^a   Karimi, A ^a   Pourafshar, N ^a   Vosoughi, A R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery stenosis; hs CRP; LDL C; Stable angina pectoris

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; EXERCISE; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING; STABLE ANGINA PECTORIS;

EID: 77954695233     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92. [10023892] [doi:10.1016/S0140-6736(98)10279-9]
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. [15364 185] [doi:10.1016/S0140-6736(04)17018-9]
3. Shemirani H, Separham KH. The relative impact of smoking or Hypertension on severity of premature coronary artery disease. Iran Red Crescent Med J 2007;9:177-181.
4. Keramati MR, Nezafati MH. Multivariate predictors of blood transfusion in patients undergoing coronary artery bypass graft in Mashhad, Iran. Iran Red Crescent Med J 2008; 10:79-83.
5. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-25. [11238291]
6. Ridker PM. Clinical application of Creactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. [12551853] [doi:10.1161/01.CIR.0000053730.47739.3C]
7. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982;389:39-48. [7046585] [doi:10.1111/j.1749-6632.1982.tb22124.x]
8. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y, Djoussé L, Eckfeldt JH; Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001;88:112-7. [11448405] [doi:10.1016/S0002-9149(01)01603-4]
9. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7. [11238260]
10. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005;96:714-6. [15774855] [doi:10.1161/01.RES.0000163015.67711.AB]
11. Schwedler SB, Amann K, Wernicke K, Krebs A, Nauck M, Wanner C, Potempa LA, Galle J. Native Creactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein Eknockout mice. Circulation 2005; 112:1016-23. [16087790] [doi:10.1161/CIRCULATIONAHA.105.556530]
12. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in active coronary artery disease. Am J Cardiol 1990;65:168-72. [2296885] [doi:10.1016/0002-9149(90)90079-G]
13. Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J 2000;140:324-8. [10925350] [doi:10.1067/mhj.2000.108244]
14. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-24. [7880233] [doi:10.1056/NEJM199408183310701]
15. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998; 31:1460-5. [9626820] [doi:10.1016/S0735-1097(98)00136-3]
16. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997; 96:4204-10. [9416883]
17. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000;35:1535-42. [10807457] [doi:10.1016/S0735-1097(00)00581-7]
18. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, Simoons ML, Topol EJ, Venge P, Wallentin L; GUSTO-IV-ACS Investigators. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 2003;41:916-24. [12651034] [doi:10.1016/S0735-1097(02)02969-8]
19. Suleiman M, Aronson D, Reisner SA, Kapeliovich MR, Markiewicz W, Levy Y, Hammerman H. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003;115:695-701. [14693321] [doi: 10.1016/j.amjmed.2003.06.008]
20. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H, Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006;47:962-8. [16516078] [doi:10.1016/j.jacc.2005.10.055]
21. Milazzo D, Biasucci LM, Luciani N, Martinelli L, Canosa C, Schiavello R, Maseri A, Possati G. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol 1999;84:459-61, A9. [10468087]
22. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL; Intermountain Heart Collaboration Study Group. Creactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002;39:632-7. [11849862] [doi:10.1016/S0735-1097(01)01804-6]
23. Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR. Biological profiles in subjects with recurrent acute coronary events compared with subjects with longstanding stable angina. Circulation 2001;103:3062-8. [11425769]
24. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-6. [9040576] [doi:10.1016/S0140-6736(96)07591-5]
25. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635-41. [7845427] [doi:10.1056/NEJM199503093321003]
26. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998; 98:839-44. [9738637]
27. Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004;25:401-8. [15033252] [doi:10.1016/j.ehj.2003.12.017]
28. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007;115:1528-36. [17372173] [doi:10.1161/CIRCULATIONAHA.106.649939]
29. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, Wians FH Jr, Grundy SM, McGuire DK. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38-43. [16380546] [doi:10.1161/CIRCULATIONAHA.105.575241]
30. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. [12551878] [doi:10.1161/01.CIR.0000052939.59093.45]
31. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007;115:1528-36. [17372173] [doi:10.1161/CIRCULATIONAHA.106.649939]
32. Gerstein HC, Pais P, Pogue J, Yusuf S. Relationship of glucose and insulin level to the risk of myocardial infarction: A case-control study. J Am Coll Cardiol 1999;33:612-9. [10080459] [doi:10.1016/S0735-1097(98)00637-8]
33. Beattie MS, Shlipak MG, Liu H, Browner WS, Schiller NB, Whooley MA. C-reactive protein and ischemia in users and nonusers of betablockers and statins: data from the Heart and Soul Study. Circulation 2003;107:245-50. [12538423] [doi:10.1161/01.CIR.0000044387.23578.E9]
34. Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med 2005;352:1611-3. [15829550] [doi: 10.1056/NEJM200504143521525]
35. Persson GR, Pettersson T, Ohlsson O, Renvert S. High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis. J Clin Periodontol 2005;32:219-24. [15766362] [doi: 10.1111/j.1600-051X.2005.00648.x]
36. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF Jr, Smith S Jr, Stone NJ, Taubert KA; American Heart Association Expert Panel on Population and Prevention Science. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003;107:645-51. [12566381] [doi:10.1161/01.CIR.0000054482.38437.13]
37. Ledue TB, Rifai N. Preanalytic and analytic sources of variations in Creactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 2003; 49:1258-71. [12881440] [doi:10.1373/49.8.1258]
38. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB. CReactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42. [9892589]
39. Guran O, Akalin F, Ayabakan C, Yagmur Dereli F, Haklar G. Highlysensitive C-reactive protein in children at risk for coronary artery disease. Acta Poediatrica 2007;1214-9.
40. Shemirani H, Separham KH. The relative impact of smoking or Hypertension on severity of premature coronary artery disease. Iran Red Crescent Med J 2007;9:177-81.